A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2
Clinical trial NCT00001812 · COMPLETED
Trial details
- NCT number
- NCT00001812
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1999-04-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.